The present disclosure described heterocyclic compounds of Formula I or, its stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms and pharmaceutically active derivative thereof and pharmaceutical compositions containing them ...

AS ATTACHED

AS ATTACHED

AS ATTACHED

AS ATTACHED

AS ATTACHED

ABSTRACT RECOMBINANT CONSTRUCT, IMMUNOGENIC COMPOSITION AGAINST DENGUE VIRUS AND IMPLEMENTATION THEREOF The present disclosure provides recombinant immunogenic compositions against Dengue serotypes. In particular, the present disclosure discloses the recombinant construct comprising a nucleic acid fragment encodin...

ABSTRACT AN ANTIBACTERIAL PARENTERAL FORMULATION AND METHODS THEREOF The present disclosure provides a formulation comprising a compound of Formula (I) or its salt thereof with a solubilising agent, a hydrotropic agent, and a pH modifier. The present disclosure also provides a lyophilized formulation and a reconst...

ABSTRACT A PROCESS OF PREPARATION OF AN ANTIBACTERIAL COMPOUND AND ITS INTERMEDIATES THEREOF The present disclosure provides a process of preparation of an antibacterial compound of Formula I, (S)-6-(5-(((2-(7-fluoro-1-methyl-2-oxo-1,2-5 dihydroquinolin-8-yl) ethyl) amino) methyl)-2-oxooxazolidin-3-yl)-2H-pyrazino...

ABSTRACT TRIAMINO PYRIMIDINE COMPOUNDS AS CDK7 INHIBITORS AND METHODS THEREOF The present disclosure provides triamino pyrimidine compounds of Formula (I), its pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, 5 polymorphs, or pharmaceutically active derivatives thereof as CDK7 inhibitor...

ABSTRACT INDANOL SUBSTITUTED DIAMINO PYRIMIDINE CARBOXAMIDES AS DUAL ATM/DNA-PK INHIBITORS The present disclosure provides indanol substituted diamino pyrimidine 5 carboxamides compounds of Formula I, its pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, stereoisomers, polymorphs, or pha...